Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
116 Views
Favorite
0
Like
Facebook
Tweet
Print
Email
Resident Posters
(9-333) Evaluation of Serious Immune-related Adverse Event Incidence in 200mg Versus 400mg Pembrolizumab Regimens
Wednesday, December 6, 2023
8:30 AM - 9:30 AM
Location: Hall E, Lower Level
Co-Author(s):
Karin Thatcher, Natoya Muirhead, Erika Rugay, Jovino Hernandez
Primary Author(s)
Arlet Bacallao, PharmD
Florida